Emerging evidence supports the use of psilocybin in palliative care, yet Schedule I status uniquely limits access outside of clinical trials in the US.
Jillian Hernandez, MS, BS, BA
Advertisement
Articles by Jillian Hernandez, MS, BS, BA
Engagement and recognition of pharmacist expertise grows as state psychedelic bills expand.
Advertisement
Latest Updated Articles
Pathways to Psilocybin in Palliative CareMay 14th 2026
Advertisement
Advertisement
Trending on Pharmacy Times
1
GLP-1 RAs Linked to Lower Mortality, Amputation Risk in Patients With PAD and Type 2 Diabetes
2
Medicare's New GLP-1 Bridge Program: What Pharmacists Need to Know Before Dispensing
3
Clots, Catheters, and Clinical Pearls: Pulmonary Embolism Updates for Practicing Pharmacists
4
Pharmacists Can Help Patients Navigate GLP-1 Access, Affordability, and Long-Term Use
5